๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Anti-epileptic therapy and behaviour disturbances in children

โœ Scribed by S. Domizio; A. Verrotti; L. A. Ramenghi; G. Sabatino; G. Morgese


Publisher
Springer
Year
1993
Tongue
English
Weight
254 KB
Volume
9
Category
Article
ISSN
0256-7040

No coin nor oath required. For personal study only.

โœฆ Synopsis


In order to evaluate the effects on behaviour of some anti-epileptic drugs, we studied 300 children treated with phenobarbital and other drugs; their age ranged from 3.1 months to 15.9 years. The children were divided into two groups: group A: 197 (116 male and 81 female) children, mean age +/- SD 5.3 +/- 2.8 years, treated with phenobarbital; group B: 103 (66 male and 37 female) children, mean age 6.4 +/- 3.1 years, treated with anti-epileptic drugs other than phenobarbital. In all patients hyperactivity, irritability, disturbances of sleep, and drowsiness were investigated. The parents of patients completed a questionnaire with seven items. In group A, 150 (76.1%) children showed one or more behaviour disturbances, while in Group B a smaller number of patients 32 (31%) had such disorders. There was a significant difference between the two groups (P < 0.0001). The most frequent disorder was hyperactivity. The results of this study suggest that anti-epileptic drugs, in particular phenobarbital, can cause behaviour disturbances.


๐Ÿ“œ SIMILAR VOLUMES


Psychobehavioral disturbance in epilepti
โœ G. B. Cavazzuti; A. Nalin ๐Ÿ“‚ Article ๐Ÿ“… 1990 ๐Ÿ› Springer ๐ŸŒ English โš– 392 KB

Psychobehavioral disturbances are frequently seen in epileptic children, but they vary in type and degree. This diversity depends on various factors: age at onset, type of epileptic syndrome and EEG pattern, and the drugs used. The early onset of an epileptic process (within the first year of life)

Plasma concentrations of valproate durin
โœ B. Lundberg; A. Nergรฅrdh; L. O. Borรฉus ๐Ÿ“‚ Article ๐Ÿ“… 1982 ๐Ÿ› Springer ๐ŸŒ English โš– 437 KB

A total of 20 children with various types of epilepsy were treated with valproate, 11 with monotherapy and 9 with valproate in combination with phenobarbitone, phenytoin, or carbamazepine. Valproate was given either every 8 or 12 h. At least two different dose levels were tried in each patient. The